NM_000390.4:c.351A>G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000390.4(CHM):​c.351A>G​(p.Ala117Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.226 in 1,205,819 control chromosomes in the GnomAD database, including 22,704 homozygotes. There are 87,776 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.17 ( 1547 hom., 5119 hem., cov: 22)
Exomes 𝑓: 0.23 ( 21157 hom. 82657 hem. )

Consequence

CHM
NM_000390.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 1.34

Publications

12 publications found
Variant links:
Genes affected
CHM (HGNC:1940): (CHM Rab escort protein) This gene encodes component A of the RAB geranylgeranyl transferase holoenzyme. In the dimeric holoenzyme, this subunit binds unprenylated Rab GTPases and then presents them to the catalytic Rab GGTase subunit for the geranylgeranyl transfer reaction. Rab GTPases need to be geranylgeranyled on either one or two cysteine residues in their C-terminus to localize to the correct intracellular membrane. Mutations in this gene are a cause of choroideremia; also known as tapetochoroidal dystrophy (TCD). This X-linked disease is characterized by progressive dystrophy of the choroid, retinal pigment epithelium and retina. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Mar 2016]
CHM Gene-Disease associations (from GenCC):
  • choroideremia
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P, ClinGen, Illumina

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.64).
BP6
Variant X-85964016-T-C is Benign according to our data. Variant chrX-85964016-T-C is described in ClinVar as Benign. ClinVar VariationId is 255991.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.34 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.248 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CHMNM_000390.4 linkc.351A>G p.Ala117Ala synonymous_variant Exon 5 of 15 ENST00000357749.7 NP_000381.1 P24386-1A8K545

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CHMENST00000357749.7 linkc.351A>G p.Ala117Ala synonymous_variant Exon 5 of 15 1 NM_000390.4 ENSP00000350386.2 P24386-1
CHMENST00000467744.2 linkn.126+63475A>G intron_variant Intron 2 of 2 5

Frequencies

GnomAD3 genomes
AF:
0.170
AC:
18728
AN:
110125
Hom.:
1549
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.0352
Gnomad AMI
AF:
0.336
Gnomad AMR
AF:
0.159
Gnomad ASJ
AF:
0.255
Gnomad EAS
AF:
0.109
Gnomad SAS
AF:
0.0875
Gnomad FIN
AF:
0.163
Gnomad MID
AF:
0.260
Gnomad NFE
AF:
0.251
Gnomad OTH
AF:
0.195
GnomAD2 exomes
AF:
0.187
AC:
33772
AN:
180276
AF XY:
0.189
show subpopulations
Gnomad AFR exome
AF:
0.0320
Gnomad AMR exome
AF:
0.135
Gnomad ASJ exome
AF:
0.260
Gnomad EAS exome
AF:
0.115
Gnomad FIN exome
AF:
0.184
Gnomad NFE exome
AF:
0.255
Gnomad OTH exome
AF:
0.221
GnomAD4 exome
AF:
0.232
AC:
254083
AN:
1095643
Hom.:
21157
Cov.:
31
AF XY:
0.229
AC XY:
82657
AN XY:
361249
show subpopulations
African (AFR)
AF:
0.0330
AC:
868
AN:
26333
American (AMR)
AF:
0.137
AC:
4787
AN:
34978
Ashkenazi Jewish (ASJ)
AF:
0.263
AC:
5074
AN:
19297
East Asian (EAS)
AF:
0.147
AC:
4439
AN:
30188
South Asian (SAS)
AF:
0.0962
AC:
5154
AN:
53584
European-Finnish (FIN)
AF:
0.187
AC:
7582
AN:
40469
Middle Eastern (MID)
AF:
0.223
AC:
920
AN:
4118
European-Non Finnish (NFE)
AF:
0.256
AC:
215456
AN:
840669
Other (OTH)
AF:
0.213
AC:
9803
AN:
46007
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
6685
13370
20054
26739
33424
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7462
14924
22386
29848
37310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.170
AC:
18722
AN:
110176
Hom.:
1547
Cov.:
22
AF XY:
0.158
AC XY:
5119
AN XY:
32418
show subpopulations
African (AFR)
AF:
0.0351
AC:
1069
AN:
30444
American (AMR)
AF:
0.159
AC:
1629
AN:
10228
Ashkenazi Jewish (ASJ)
AF:
0.255
AC:
667
AN:
2619
East Asian (EAS)
AF:
0.109
AC:
381
AN:
3481
South Asian (SAS)
AF:
0.0866
AC:
221
AN:
2552
European-Finnish (FIN)
AF:
0.163
AC:
939
AN:
5754
Middle Eastern (MID)
AF:
0.257
AC:
54
AN:
210
European-Non Finnish (NFE)
AF:
0.251
AC:
13244
AN:
52727
Other (OTH)
AF:
0.196
AC:
292
AN:
1488
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
535
1070
1606
2141
2676
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
198
396
594
792
990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.218
Hom.:
2010
Bravo
AF:
0.167

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Choroideremia Benign:2
Nov 20, 2019
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Retinal dystrophy Benign:1
Oct 01, 2023
Dept Of Ophthalmology, Nagoya University
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.64
CADD
Benign
9.5
DANN
Benign
0.62
PhyloP100
1.3
Mutation Taster
=297/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10217950; hg19: chrX-85219021; COSMIC: COSV63300735; API